Pharmaceutical Composition for Controlling Blood Sugar
Copyright © Targeted News Service 2024
2024-04-16
ALEXANDRIA, Virginia, April 16 -- BEIJING HEBABIZ BIOTECHNOLOGY CO., INC., Beijing, China has been assigned a patent (No. US 11957726 B2, initially filed Sept. 8, 2017) developed by James Zhou, Westport, Connecticut, for "Pharmaceutical composition for controlling blood sugar." . . .